Sarah was diagnosed with stage II breast cancer and underwent chemotherapy. However, after a few months, she started feeling uncertain about the treatment's effectiveness. With OncoTrace, her oncologist was able to monitor her circulating tumor cells (CTCs) in real time. The results showed a decrease in CTC count, confirming that the therapy was working.

John was living with prostate cancer and was initially skeptical about alternative monitoring techniques. Traditional scans didn’t provide the full picture, so his doctor recommended OncoTrace to track the behavior of his cancer cells. By identifying key phenotype markers, John’s medical team adjusted his treatment plan, preventing unnecessary procedures. Today, John is back to enjoying his retirement with peace of mind.

Emily was diagnosed with ovarian cancer, and her doctors needed to ensure her treatment was truly effective. Instead of relying only on scans, they used OncoTrace to detect stemness markers, which indicated whether the cancer was aggressive or responding to treatment. This personalized approach allowed her doctors to switch to a more effective therapy early on. Now in remission, Emily is grateful for the power of precision medicine.

After undergoing surgery for colorectal cancer, Michael wanted to ensure there were no lingering cancer cells in his body. He used OncoTrace for post-treatment monitoring. The test showed no detectable CTCs, giving him the reassurance that his body was free from active cancer. Today, Michael is an advocate for early detection and precision cancer care.